person · Reporting owner

KOSECOFF JACQUELINE B

Disclosed activity across 8 companies

Tapewire entity: 42934
SEC CIK: 0001209524

Reported relationships

Latest disclosed role at each company.

Company	Last reported as	Report date	Published
Alignment Healthcare, Inc.ALHC · Entity 4269	Director	March 13, 2026	March 17, 2026
GoodRx Holdings, Inc.GDRX · Entity 4838	Director	December 31, 2022	February 13, 2023
HOULIHAN LOKEY, INC.HLI · Entity 3553	Director	May 22, 2025	May 23, 2025
SEALED AIR CORP/DESEE · Entity 53140	Director	May 21, 2020	May 22, 2020
STERIS plcSTE · Entity 3228	Director	August 08, 2024	August 12, 2024
TRINET GROUP, INC.TNET · Entity 4202	Director	May 28, 2026	June 01, 2026

Disclosed balances

About these balances

Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.

Alignment Healthcare, Inc.

Report date March 13, 2026 · Filed March 17, 2026

Security / award	Ownership account	Disclosed shares / units	Disclosure context
Common StockSEC Table I · non-derivative	Direct	303,963	Reported balance After 2026-03-13 transaction · row 1 1 source row Row 1 · 2026-03-13 · Grant · Acquired 13,096 · Balance 303,963 F1: Represents 13,096 restricted stock units, each restricted stock unit representing a right to receive one share of Common Stock of the Company, all of which will vest on the one-year anniversary of the grant date unless the reporting person ceases to serve as a member of the Board of Directors prior to such date.

Filing footnotes · ownership attribution and instrument terms

F1: Represents 13,096 restricted stock units, each restricted stock unit representing a right to receive one share of Common Stock of the Company, all of which will vest on the one-year anniversary of the grant date unless the reporting person ceases to serve as a member of the Board of Directors prior to such date.

GoodRx Holdings, Inc.

Report date December 31, 2022 · Filed February 13, 2023

Security / award	Ownership account	Disclosed shares / units	Disclosure context
Class A Common StockSEC Table I · non-derivative	Direct	27,440	Reported balance After 2022-08-17 transaction · row 1 1 source row Row 1 · 2022-08-17 · Gift · Disposed 6,138 · Balance 27,440 F1: On August 17, 2022, the Reporting Person transferred 6,138 shares of Class A common stock to the Robert H. Brook and Jacqueline B. Kosecoff Family Trust, of which the Reporting Person and her spouse serve as trustees and are the sole beneficiaries.
Class A Common StockSEC Table I · non-derivative	IndirectBy Trust	6,138	Reported balance After 2022-08-17 transaction · row 2 Account identity is unresolved; indirect or unspecified ownership is not merged. 1 source row Row 2 · 2022-08-17 · Gift · Acquired 6,138 · Balance 6,138 F1: On August 17, 2022, the Reporting Person transferred 6,138 shares of Class A common stock to the Robert H. Brook and Jacqueline B. Kosecoff Family Trust, of which the Reporting Person and her spouse serve as trustees and are the sole beneficiaries.

Filing footnotes · ownership attribution and instrument terms

F1: On August 17, 2022, the Reporting Person transferred 6,138 shares of Class A common stock to the Robert H. Brook and Jacqueline B. Kosecoff Family Trust, of which the Reporting Person and her spouse serve as trustees and are the sole beneficiaries.

HOULIHAN LOKEY, INC.

Report date May 22, 2025 · Filed May 23, 2025

Security / award	Ownership account	Disclosed shares / units	Disclosure context
CLASS A COMMON STOCKSEC Table I · non-derivative	Direct	15,316	Reported balance After 2025-05-22 transaction · row 1 1 source row Row 1 · 2025-05-22 · Grant · Acquired 563 · Balance 15,316

SEALED AIR CORP/DE

Report date May 21, 2020 · Filed May 22, 2020

Security / award	Ownership account	Disclosed shares / units	Disclosure context
Common StockSEC Table I · non-derivative	Direct	4,167	Reported balance After 2020-05-21 transaction · row 1 1 source row Row 1 · 2020-05-21 · Grant · Acquired 4,167 · Balance 4,167 F1: Award made under the 2014 Omnibus Incentive Plan.
Common StockSEC Table I · non-derivative	IndirectBy Trust	40,937	Reported balance Holding disclosure · report date 2020-05-21 · row 2 Holding and transaction disclosures are not merged. 1 source row Row 2 · Balance 40,937 F2: Shares held indirectly in a trust for the benefit of Dr. Kosecoff and her husband.
Stock UnitsSEC Table II · derivative / convertible security	Direct	8,744	Reported balance Holding disclosure · report date 2020-05-21 · row 3 Instrument identity requires review; Table II rows are not merged. 1 source row Row 3 · Balance 8,744 F3: 1-for-1 F4: The units are to be settled in shares of Common Stock (with certain exceptions specified in the Corporation's Deferred Compensation Plan for Directors) following the reporting person's retirement from the Board of Directors. F5: Reflects the addition of units converted from dividend equivalents.

Filing footnotes · ownership attribution and instrument terms

F1: Award made under the 2014 Omnibus Incentive Plan.

F2: Shares held indirectly in a trust for the benefit of Dr. Kosecoff and her husband.

F3: 1-for-1

F4: The units are to be settled in shares of Common Stock (with certain exceptions specified in the Corporation's Deferred Compensation Plan for Directors) following the reporting person's retirement from the Board of Directors.

F5: Reflects the addition of units converted from dividend equivalents.

STERIS plc

Report date August 08, 2024 · Filed August 12, 2024

Security / award	Ownership account	Disclosed shares / units	Disclosure context
Director Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $239.68 · Expires 2034-08-08	Direct	1,388	Reported balance After 2024-08-08 transaction · row 1 Instrument identity requires review; Table II rows are not merged. 1 source row Row 1 · 2024-08-08 · Grant · Acquired 1,388 · Balance 1,388 F1: These nonqualified stock options are fully vested and are exercisable immediately.
Career Restricted Stock UnitsSEC Table II · derivative / convertible security	Direct	6,546	Reported balance After 2024-08-08 transaction · row 2 Instrument identity requires review; Table II rows are not merged. 1 source row Row 2 · 2024-08-08 · Grant · Acquired 494 · Balance 6,546 F2: Each Career Restricted Stock Unit represents the right to receive one STERIS ordinary share six months after the cessation of the Director's Board service. F3: These Career Restricted Stock Units are fully vested immediately. They will be settled in STERIS ordinary shares six months after the cessation of the Director's Board service.
Career Restricted Stock UnitsSEC Table II · derivative / convertible security	Direct	6,988	Reported balance After 2024-08-08 transaction · row 3 Instrument identity requires review; Table II rows are not merged. 1 source row Row 3 · 2024-08-08 · Grant · Acquired 442 · Balance 6,988 F2: Each Career Restricted Stock Unit represents the right to receive one STERIS ordinary share six months after the cessation of the Director's Board service. F4: These Career Restricted Stock Units were issued to the Reporting Person in lieu of fees of $106,000 . F3: These Career Restricted Stock Units are fully vested immediately. They will be settled in STERIS ordinary shares six months after the cessation of the Director's Board service.

Filing footnotes · ownership attribution and instrument terms

F1: These nonqualified stock options are fully vested and are exercisable immediately.

F2: Each Career Restricted Stock Unit represents the right to receive one STERIS ordinary share six months after the cessation of the Director's Board service.

F3: These Career Restricted Stock Units are fully vested immediately. They will be settled in STERIS ordinary shares six months after the cessation of the Director's Board service.

F4: These Career Restricted Stock Units were issued to the Reporting Person in lieu of fees of $106,000 .

TRINET GROUP, INC.

Report date May 28, 2026 · Filed June 01, 2026

Security / award	Ownership account	Disclosed shares / units	Disclosure context
Common StockSEC Table I · non-derivative	Direct	4,735	Last balance in matching sequence After 2026-05-29 transaction · row 2 Source-order balances reconcile. Account continuity and personal attribution are not independently verified. 2 source rows Row 1 · 2026-05-28 · Grant · Acquired 4,735 · Balance 7,384 F1: Reflects the grant of Restricted Stock Units that convert into Common Stock, par value $0.000025 per share, of the Issuer, on a one-for-one basis. The Restricted Stock Units will vest 100% on the earlier of the 12-month anniversary of the date of grant and the trading day preceding the date of the Company's 2027 Annual Meeting of the Stockholders, subject to the director's continued service. The Restricted Stock Units are also subject to accelerated vesting upon certain events. F2: The total securities beneficially owned includes shares of unvested restricted stock units. Row 2 · 2026-05-29 · Gift · Disposed 2,649 · Balance 4,735 F3: Represents a transfer of shares to a trust, of which the reporting person and her spouse are trustees and beneficiaries of the trust. F2: The total securities beneficially owned includes shares of unvested restricted stock units.
Common StockSEC Table I · non-derivative	IndirectBy Trust	17,007	Reported balance After 2026-05-29 transaction · row 3 Account identity is unresolved; indirect or unspecified ownership is not merged. 1 source row Row 3 · 2026-05-29 · Gift · Acquired 2,649 · Balance 17,007 F3: Represents a transfer of shares to a trust, of which the reporting person and her spouse are trustees and beneficiaries of the trust. F4: Shares held directly by the Robert H. Brook and Jacqueline B. Kosecoff Family Trust (the "Trust"). The Reporting Person and her spouse serve as trustees and beneficiaries of the Trust.

Filing footnotes · ownership attribution and instrument terms

F1: Reflects the grant of Restricted Stock Units that convert into Common Stock, par value $0.000025 per share, of the Issuer, on a one-for-one basis. The Restricted Stock Units will vest 100% on the earlier of the 12-month anniversary of the date of grant and the trading day preceding the date of the Company's 2027 Annual Meeting of the Stockholders, subject to the director's continued service. The Restricted Stock Units are also subject to accelerated vesting upon certain events.

F2: The total securities beneficially owned includes shares of unvested restricted stock units.

F3: Represents a transfer of shares to a trust, of which the reporting person and her spouse are trustees and beneficiaries of the trust.

F4: Shares held directly by the Robert H. Brook and Jacqueline B. Kosecoff Family Trust (the "Trust"). The Reporting Person and her spouse serve as trustees and beneficiaries of the Trust.

Past disclosures · reporting ended (2)

No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.

ATHENAHEALTH INC

Report date February 11, 2019 · Filed February 13, 2019

Section 16 reporting ended · disclosed 2019-02-13. Current position is not established by this disclosure.

Security / award	Ownership account	Disclosed shares / units	Disclosure context
Common StockSEC Table I · non-derivative	Direct	0	Reported balance After 2019-02-11 transaction · row 1 1 source row Row 1 · 2019-02-11 · Disposition to issuer · Disposed 12,806 · Balance 0 F1: Pursuant to the terms of the Agreement and Plan of Merger, dated as of November 11, 2018, among athenahealth, Inc. (the "Company"), May Holding Corp., and May Merger Sub Inc. (the "Merger Agreement"), on February 11, 2019, each share of athenahealth common stock, par value $0.01 ("Common Stock") issued and outstanding immediately prior to the Effective Time (as defined in the Merger Agreement) and not otherwise excluded pursuant to the terms of the Merger Agreement, was converted into the right to receive $135.00 per share in cash (the "Merger Consideration"), subject to any required withholding taxes. F2: 1,931 of these securities represent shares of Common Stock underlying athenahealth restricted stock unit ("RSU") awards subject to time-based vesting. Pursuant to the Merger Agreement, on February 11, 2019, unvested RSUs outstanding immediately prior to the Effective Time were canceled and converted into the right to receive the Merger Consideration.

Filing footnotes · ownership attribution and instrument terms

F1: Pursuant to the terms of the Agreement and Plan of Merger, dated as of November 11, 2018, among athenahealth, Inc. (the "Company"), May Holding Corp., and May Merger Sub Inc. (the "Merger Agreement"), on February 11, 2019, each share of athenahealth common stock, par value $0.01 ("Common Stock") issued and outstanding immediately prior to the Effective Time (as defined in the Merger Agreement) and not otherwise excluded pursuant to the terms of the Merger Agreement, was converted into the right to receive $135.00 per share in cash (the "Merger Consideration"), subject to any required withholding taxes.

F2: 1,931 of these securities represent shares of Common Stock underlying athenahealth restricted stock unit ("RSU") awards subject to time-based vesting. Pursuant to the Merger Agreement, on February 11, 2019, unvested RSUs outstanding immediately prior to the Effective Time were canceled and converted into the right to receive the Merger Consideration.

STERIS plc

Report date March 28, 2019 · Filed March 28, 2019

Section 16 reporting ended · disclosed 2019-03-28. Current position is not established by this disclosure.

Security / award	Ownership account	Disclosure context
Ordinary Shares, 10 pence par valueSEC Table I · non-derivative	IndirectSee Footnote Below	Reported balance After 2019-03-28 transaction · row 1 Account identity is unresolved; indirect or unspecified ownership is not merged. 1 source row Row 1 · 2019-03-28 · Disposition to issuer · Disposed 42,830 · Balance 0 F1: Represents ordinary shares of STERIS plc, a public limited company organized under the laws of England and Wales ("Old STERIS"), cancelled pursuant to a court-approved scheme of arrangement under English law (the "Scheme"). In connection with the Scheme, the reporting person received ordinary shares of STERIS plc, a public limited company organized under the laws of Ireland ("STERIS"), in an amount equal to the number of the reporting person's cancelled Old STERIS shares. The reporting person's STERIS shares will be subject to terms and conditions, including restrictions, substantially identical to those that were applicable to the Old STERIS shares. Following the completion of the Scheme, STERIS became the ultimate holding company of Old STERIS. F2: These ordinary shares are held in a revocable family trust of the Reporting Person and the Reporting Person's spouse, as Co-Trustees. 1,260 shares that had been directly held were transferred to the trust on November 23, 2018.
Director Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $28.08 · Expires 2019-07-31	Direct	Reported balance After 2019-03-28 transaction · row 2 Instrument identity requires review; Table II rows are not merged. 1 source row Row 2 · 2019-03-28 · Disposition to issuer · Disposed 3,609 · Balance 0 F3: This option is fully vested. This option was assumed by STERIS under the Scheme and converted to an option to purchase 3,609 ordinary shares of STERIS for $28.08 per share, subject to the same terms and conditions that were applicable to the original Old STERIS option.
Director Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $32.34 · Expires 2020-08-04	Direct	Reported balance After 2019-03-28 transaction · row 3 Instrument identity requires review; Table II rows are not merged. 1 source row Row 3 · 2019-03-28 · Disposition to issuer · Disposed 3,133 · Balance 0 F4: This option is fully vested. This option was assumed by STERIS under the Scheme and converted to an option to purchase 3,133 ordinary shares of STERIS for $32.34 per share, subject to the same terms and conditions that were applicable to the original Old STERIS option.
Director Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $31.61 · Expires 2021-08-03	Direct	Reported balance After 2019-03-28 transaction · row 4 Instrument identity requires review; Table II rows are not merged. 1 source row Row 4 · 2019-03-28 · Disposition to issuer · Disposed 3,121 · Balance 0 F5: This option is fully vested. This option was assumed by STERIS under the Scheme and converted to an option to purchase 3,121 ordinary shares of STERIS for $31.61 per share, subject to the same terms and conditions that were applicable to the original Old STERIS option.
Director Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $32.36 · Expires 2022-08-03	Direct	Reported balance After 2019-03-28 transaction · row 5 Instrument identity requires review; Table II rows are not merged. 1 source row Row 5 · 2019-03-28 · Disposition to issuer · Disposed 3,218 · Balance 0 F6: This option is fully vested. This option was assumed by STERIS under the Scheme and converted to an option to purchase 3,218 ordinary shares of STERIS for $32.36 per share, subject to the same terms and conditions that were applicable to the original Old STERIS option.
Director Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $43.92 · Expires 2023-08-08	Direct	Reported balance After 2019-03-28 transaction · row 6 Instrument identity requires review; Table II rows are not merged. 1 source row Row 6 · 2019-03-28 · Disposition to issuer · Disposed 4,657 · Balance 0 F7: This option is fully vested. This option was assumed by STERIS under the Scheme and converted to an option to purchase 4,657 ordinary shares of STERIS for $43.92 per share, subject to the same terms and conditions that were applicable to the original Old STERIS option.
Director Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $51.53 · Expires 2024-08-06	Direct	Reported balance After 2019-03-28 transaction · row 7 Instrument identity requires review; Table II rows are not merged. 1 source row Row 7 · 2019-03-28 · Disposition to issuer · Disposed 4,584 · Balance 0 F8: This option is fully vested. This option was assumed by STERIS under the Scheme and converted to an option to purchase 4,584 ordinary shares of STERIS for $51.53 per share, subject to the same terms and conditions that were applicable to the original Old STERIS option.
Director Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $64.05 · Expires 2025-08-31	Direct	Reported balance After 2019-03-28 transaction · row 8 Instrument identity requires review; Table II rows are not merged. 1 source row Row 8 · 2019-03-28 · Disposition to issuer · Disposed 4,110 · Balance 0 F9: This option is fully vested. This option was assumed by STERIS under the Scheme and converted to an option to purchase 4,110 ordinary shares of STERIS for $64.05 per share, subject to the same terms and conditions that were applicable to the original Old STERIS option.
Director Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $71.40 · Expires 2026-08-10	Direct	Reported balance After 2019-03-28 transaction · row 9 Instrument identity requires review; Table II rows are not merged. 1 source row Row 9 · 2019-03-28 · Disposition to issuer · Disposed 3,781 · Balance 0 F10: This option is fully vested. This option was assumed by STERIS under the Scheme and converted to an option to purchase 3,781 ordinary shares of STERIS for $71.40 per share, subject to the same terms and conditions that were applicable to the original Old STERIS option.
Director Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $86.23 · Expires 2027-08-09	Direct	Reported balance After 2019-03-28 transaction · row 10 Instrument identity requires review; Table II rows are not merged. 1 source row Row 10 · 2019-03-28 · Disposition to issuer · Disposed 927 · Balance 0 F11: This option is fully vested. This option was assumed by STERIS under the Scheme and converted to an option to purchase 927 ordinary shares of STERIS for $86.23 per share, subject to the same terms and conditions that were applicable to the original Old STERIS option.
Director Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $114.74 · Expires 2028-08-09	Direct	Reported balance After 2019-03-28 transaction · row 11 Instrument identity requires review; Table II rows are not merged. 1 source row Row 11 · 2019-03-28 · Disposition to issuer · Disposed 436 · Balance 0 F12: This option is fully vested. This option was assumed by STERIS under the Scheme and converted to an option to purchase 436 ordinary shares of STERIS for $114.74 per share, subject to the same terms and conditions that were applicable to the original Old STERIS option.
Career Restricted Stock UnitsSEC Table II · derivative / convertible security	Direct	Reported balance After 2019-03-28 transaction · row 12 Instrument identity requires review; Table II rows are not merged. 1 source row Row 12 · 2019-03-28 · Disposition to issuer · Disposed 3,184 · Balance 0 F13: These career restricted stock units were assumed by STERIS pursuant to the Scheme and converted to career restricted stock units of STERIS representing the right to receive 3,184 STERIS ordinary shares. These career restricted stock units are fully vested and will be settled in STERIS ordinary shares six months after the cessation of the reporting person's board service, subject to the terms and conditions of the award agreement.

Filing footnotes · ownership attribution and instrument terms

F1: Represents ordinary shares of STERIS plc, a public limited company organized under the laws of England and Wales ("Old STERIS"), cancelled pursuant to a court-approved scheme of arrangement under English law (the "Scheme"). In connection with the Scheme, the reporting person received ordinary shares of STERIS plc, a public limited company organized under the laws of Ireland ("STERIS"), in an amount equal to the number of the reporting person's cancelled Old STERIS shares. The reporting person's STERIS shares will be subject to terms and conditions, including restrictions, substantially identical to those that were applicable to the Old STERIS shares. Following the completion of the Scheme, STERIS became the ultimate holding company of Old STERIS.

F2: These ordinary shares are held in a revocable family trust of the Reporting Person and the Reporting Person's spouse, as Co-Trustees. 1,260 shares that had been directly held were transferred to the trust on November 23, 2018.

F3: This option is fully vested. This option was assumed by STERIS under the Scheme and converted to an option to purchase 3,609 ordinary shares of STERIS for $28.08 per share, subject to the same terms and conditions that were applicable to the original Old STERIS option.

F4: This option is fully vested. This option was assumed by STERIS under the Scheme and converted to an option to purchase 3,133 ordinary shares of STERIS for $32.34 per share, subject to the same terms and conditions that were applicable to the original Old STERIS option.

F5: This option is fully vested. This option was assumed by STERIS under the Scheme and converted to an option to purchase 3,121 ordinary shares of STERIS for $31.61 per share, subject to the same terms and conditions that were applicable to the original Old STERIS option.

F6: This option is fully vested. This option was assumed by STERIS under the Scheme and converted to an option to purchase 3,218 ordinary shares of STERIS for $32.36 per share, subject to the same terms and conditions that were applicable to the original Old STERIS option.

F7: This option is fully vested. This option was assumed by STERIS under the Scheme and converted to an option to purchase 4,657 ordinary shares of STERIS for $43.92 per share, subject to the same terms and conditions that were applicable to the original Old STERIS option.

F8: This option is fully vested. This option was assumed by STERIS under the Scheme and converted to an option to purchase 4,584 ordinary shares of STERIS for $51.53 per share, subject to the same terms and conditions that were applicable to the original Old STERIS option.

F9: This option is fully vested. This option was assumed by STERIS under the Scheme and converted to an option to purchase 4,110 ordinary shares of STERIS for $64.05 per share, subject to the same terms and conditions that were applicable to the original Old STERIS option.

F10: This option is fully vested. This option was assumed by STERIS under the Scheme and converted to an option to purchase 3,781 ordinary shares of STERIS for $71.40 per share, subject to the same terms and conditions that were applicable to the original Old STERIS option.

F11: This option is fully vested. This option was assumed by STERIS under the Scheme and converted to an option to purchase 927 ordinary shares of STERIS for $86.23 per share, subject to the same terms and conditions that were applicable to the original Old STERIS option.

F12: This option is fully vested. This option was assumed by STERIS under the Scheme and converted to an option to purchase 436 ordinary shares of STERIS for $114.74 per share, subject to the same terms and conditions that were applicable to the original Old STERIS option.

F13: These career restricted stock units were assumed by STERIS pursuant to the Scheme and converted to career restricted stock units of STERIS representing the right to receive 3,184 STERIS ordinary shares. These career restricted stock units are fully vested and will be settled in STERIS ordinary shares six months after the cessation of the reporting person's board service, subject to the terms and conditions of the award agreement.

Transaction history

JSON API

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction date	Company	Activity / security	Shares / units	Reported price	Reported value	Details
August 10, 2021 Filed Aug 12, 2021 20:36 UTC	STERIS plc STE · Entity 3228	GrantCareer Restricted Stock Units · Derivative	508	$0.00	$0.00	Disclosure SEC source: 0001209191-21-051117 · doc4.xml · derivative · entry 2 KOSECOFF JACQUELINE B · CIK 0001209524 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,718 Underlying: Ordinary Shares · 508 shares Expires not disclosed F2 · derivative.exercise_price: Each Career Restricted Stock Unit represents the right to receive one STERIS ordinary share six months after the cessation of the Director's Board service. F3 · derivative.exercise_date: These Career Restricted Stock Units are fully vested immediately. They will be settled in STERIS ordinary shares six months after the cessation of the Director's Board service. F3 · derivative.expiration_date: These Career Restricted Stock Units are fully vested immediately. They will be settled in STERIS ordinary shares six months after the cessation of the Director's Board service. Read SEC document
August 10, 2021 Filed Aug 12, 2021 20:36 UTC	STERIS plc STE · Entity 3228	GrantDirector Stock Option (right to buy) · Derivative	2,027	$0.00 Strike: $217.62	$0.00	Disclosure SEC source: 0001209191-21-051117 · doc4.xml · derivative · entry 1 KOSECOFF JACQUELINE B · CIK 0001209524 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,027 Underlying: Ordinary Shares · 2,027 shares Expires 2031-08-10 F1 · derivative.exercise_date: These nonqualified stock options are fully vested and are exercisable immediately. Read SEC document
June 10, 2021 Filed Jun 14, 2021 20:45 UTC	GoodRx Holdings, Inc. GDRX · Entity 4838	GrantClass A Common Stock	6,138	$0.00	$0.00	Disclosure SEC source: 0000899243-21-023574 · doc4.xml · nonDerivative · entry 1 KOSECOFF JACQUELINE B · CIK 0001209524 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,138 F1 · shares: Reflects restricted stock units. Each restricted stock unit represents a contingent right to receive one share of Class A common stock. The restricted stock units vest in full on the earlier of (i) the one-year anniversary of June 10, 2021 and (ii) the date of the 2022 Annual Meeting of Stockholders, subject to continued service through the applicable vesting date. Read SEC document
May 26, 2021 Filed May 28, 2021 20:49 UTC	HOULIHAN LOKEY, INC. HLI · Entity 3553	GrantCLASS A COMMON STOCK	1,195	$0.00	$0.00	Disclosure SEC source: 0001302215-21-000050 · wf-form4_162223494651082.xml · nonDerivative · entry 1 KOSECOFF JACQUELINE B · CIK 0001209524 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,937 Read SEC document
May 21, 2021 Filed May 24, 2021 20:33 UTC	STERIS plc STE · Entity 3228	Exercise / conversionEmployee Stock Option (right to buy) · Derivative	3,121	$0.00 Strike: $31.61	$0.00	Disclosure SEC source: 0001209191-21-035332 · doc4.xml · derivative · entry 4 KOSECOFF JACQUELINE B · CIK 0001209524 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Ordinary Shares · 3,121 shares Expires 2021-08-03 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: This option to purchase 3,121 STERIS ordinary shares, which is fully vested, was received in conjunction with the Redomiciliation of the entity organized under the laws of the U.K. and formerly named STERIS plc ("Old STERIS") in exchange for an option to purchase 3,121 Old STERIS ordinary shares for $31.61 per share, subject to the same terms and conditions as the original Old STERIS stock option, except as otherwise required by law. Read SEC document
May 21, 2021 Filed May 24, 2021 20:33 UTC	STERIS plc STE · Entity 3228	SaleOrdinary Shares	3,121	$192.59	$601,073.39	Disclosure SEC source: 0001209191-21-035332 · doc4.xml · nonDerivative · entry 2 KOSECOFF JACQUELINE B · CIK 0001209524 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · price: Price reflects a weighted average sale price for multiple transactions ranging from $192.92 to $193.025 per share, inclusive. The Reporting Person undertakes to provide, upon request by the SEC Staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price. Read SEC document
May 21, 2021 Filed May 24, 2021 20:33 UTC	STERIS plc STE · Entity 3228	Exercise / conversionOrdinary Shares	3,121	$31.61	$98,654.81	Disclosure SEC source: 0001209191-21-035332 · doc4.xml · nonDerivative · entry 1 KOSECOFF JACQUELINE B · CIK 0001209524 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,121 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document
March 30, 2021 Filed Apr 1, 2021 22:49 UTC	Alignment Healthcare, Inc. ALHC · Entity 4269	GrantCommon Stock	10,000	$18.00	$180,000.00	Disclosure SEC source: 0000899243-21-014408 · doc4.xml · nonDerivative · entry 3 KOSECOFF JACQUELINE B · CIK 0001209524 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 60,640 F3 · kind: Represents 10,000 shares of Common Stock purchased through a directed share program at the initial offering price of the Common Stock. Read SEC document
March 30, 2021 Filed Apr 12, 2021 22:48 UTC Amendment	Alignment Healthcare, Inc. ALHC · Entity 4269	GrantCommon Stock	10,000	$18.00	$180,000.00	Disclosure SEC source: 0000899243-21-015550 · doc4a.xml · nonDerivative · entry 3 KOSECOFF JACQUELINE B · CIK 0001209524 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 192,983 F3 · kind: Represents 10,000 shares of Common Stock purchased through a directed share program at the initial offering price of the Common Stock. Read SEC document
March 30, 2021 Filed Jan 19, 2022 23:00 UTC	TRINET GROUP, INC. TNET · Entity 4202	GiftCommon Stock	5,773	$0.00	$0.00	Disclosure SEC source: 0000937098-22-000026 · wf-form5_164263319320842.xml · nonDerivative · entry 2 KOSECOFF JACQUELINE B · CIK 0001209524 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Trust Disclosed balance after: 5,984 F1 · ownership.nature: Shares held directly by the Robert H. Brook and Jacqueline B. Kosecoff Family Trust (the "Trust"). The Reporting Person and her spouse serve as trustees and beneficiaries of the Trust. Read SEC document
March 30, 2021 Filed Jan 19, 2022 23:00 UTC	TRINET GROUP, INC. TNET · Entity 4202	GiftCommon Stock	5,773	$0.00	$0.00	Disclosure SEC source: 0000937098-22-000026 · wf-form5_164263319320842.xml · nonDerivative · entry 1 KOSECOFF JACQUELINE B · CIK 0001209524 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,576 Read SEC document
March 25, 2021 Filed Apr 1, 2021 22:49 UTC	Alignment Healthcare, Inc. ALHC · Entity 4269	GrantCommon Stock	33,333	$0.00	$0.00	Disclosure SEC source: 0000899243-21-014408 · doc4.xml · nonDerivative · entry 2 KOSECOFF JACQUELINE B · CIK 0001209524 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,460 F2 · kind: Represents 33,333 shares of restricted Common Stock of the Company that will vest in equal annual installments on each of the first three anniversaries of the IPO unless Ms. Kosecoff is removed for cause or resigns prior to such dates. The securities covered by such transaction were previously included on Ms. Kosecoff's Form 3. Read SEC document
March 25, 2021 Filed Apr 1, 2021 22:49 UTC	Alignment Healthcare, Inc. ALHC · Entity 4269	GrantCommon Stock, par value $0.001 per share ("Common Stock")	17,127	$0.00	$0.00	Disclosure SEC source: 0000899243-21-014408 · doc4.xml · nonDerivative · entry 1 KOSECOFF JACQUELINE B · CIK 0001209524 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,127 F1 · kind: Represents 11,418 shares of Common Stock of Alignment Healthcare, Inc. (the "Company") and 5,709 restricted shares of Common Stock of the Company that will vest upon a change of control of the Company or otherwise (A) if received in exchange for pre-IPO (as defined below) transaction-based stock appreciation rights, on the later of (x) the four-year anniversary of the initial vesting date, or (y) 50% on the first anniversary of Company's initial public offering (the "IPO") and 50% on the second anniversary of the IPO, in each case, subject to Ms. Kosecoff's continued employment or service on each such vesting date and (B) if received in exchange for pre-IPO service-based stock appreciation rights, according to the pre-IPO vesting schedule of the pre-IPO service-based stock appreciation rights. The securities covered by such transaction were previously included on Ms. Kosecoff's Form 3. Read SEC document
March 25, 2021 Filed Apr 12, 2021 22:48 UTC Amendment	Alignment Healthcare, Inc. ALHC · Entity 4269	GrantCommon Stock	33,333	$0.00	$0.00	Disclosure SEC source: 0000899243-21-015550 · doc4a.xml · nonDerivative · entry 2 KOSECOFF JACQUELINE B · CIK 0001209524 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 182,983 F2 · kind: Represents 33,333shares of restricted Common Stock of the Company that will vest in equal annual installments on each of the first three anniversaries of the IPO unless Ms. Kosecoff is removed for cause or resigns prior to such dates. The securities covered by such transaction were previously included on Ms. Kosecoff's Form 3. Read SEC document
March 25, 2021 Filed Apr 12, 2021 22:48 UTC Amendment	Alignment Healthcare, Inc. ALHC · Entity 4269	GrantCommon Stock, par value $0.001 per share ("Common Stock")	17,127	$0.00	$0.00	Disclosure SEC source: 0000899243-21-015550 · doc4a.xml · nonDerivative · entry 1 KOSECOFF JACQUELINE B · CIK 0001209524 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 149,650 F1 · kind: Represents 11,418 shares of Common Stock of Alignment Healthcare, Inc. (the "Company") and 5,709 restricted shares of Common Stock of the Company that will vest upon a change of control of the Company or otherwise (A) if received in exchange for pre-IPO (as defined below) transaction-based stock appreciation rights, on the later of (x) the four-year anniversary of the initial vesting date, or (y) 50% on the first anniversary of Company's initial public offering (the "IPO") and 50% on the second anniversary of the IPO, in each case, subject to Ms. Kosecoff's continued employment or service on each such vesting date and (B) if received in exchange for pre-IPO service-based stock appreciation rights, according to the pre-IPO vesting schedule of the pre-IPO service-based stock appreciation rights. The securities covered by such transaction were previously included on Ms. Kosecoff's Form 3. Read SEC document
March 24, 2021 Filed Mar 26, 2021 21:49 UTC	TRINET GROUP, INC. TNET · Entity 4202	GrantCommon Stock	2,576	$0.00	$0.00	Disclosure SEC source: 0000937098-21-000101 · wf-form4_161679534984921.xml · nonDerivative · entry 1 KOSECOFF JACQUELINE B · CIK 0001209524 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,349 F1 · shares: Reflects the grant of Restricted Stock Units that convert into Common Stock, par value $0.000025 per share, of the Issuer, on a one-for-one basis. The Restricted Stock Units will vest 100% on the date of the Company's 2022 Annual Meeting of the Stockholders, subject to the director's continued service. The Restricted Stock Units are also subject to accelerated vesting upon certain events. Read SEC document
November 30, 2020 Filed Dec 1, 2020 21:33 UTC	STERIS plc STE · Entity 3228	GiftOrdinary Shares	7,644	$0.00	$0.00	Disclosure SEC source: 0001209191-20-060897 · doc4.xml · nonDerivative · entry 2 KOSECOFF JACQUELINE B · CIK 0001209524 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Below Disclosed balance after: 26,639 F2 · balance_after: 784 ordinary shares previously reported and held individually by the Reporting Person were transferred to a revocable family trust of the Reporting Person and the Reporting Person's spouse, as Co-Trustees. F1 · ownership.nature: These ordinary shares are held in a revocable family trust of the Reporting Person and the Reporting Person's spouse, as Co-Trustees. Read SEC document
November 30, 2020 Filed Dec 1, 2020 21:33 UTC	STERIS plc STE · Entity 3228	GiftOrdinary Shares	10,286	$0.00	$0.00	Disclosure SEC source: 0001209191-20-060897 · doc4.xml · nonDerivative · entry 1 KOSECOFF JACQUELINE B · CIK 0001209524 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Below Disclosed balance after: 34,283 F1 · ownership.nature: These ordinary shares are held in a revocable family trust of the Reporting Person and the Reporting Person's spouse, as Co-Trustees. Read SEC document
August 04, 2020 Filed Aug 6, 2020 20:33 UTC	STERIS plc STE · Entity 3228	Tax withholdingOrdinary Shares	532	$158.00	$84,056.00	Disclosure SEC source: 0001209191-20-045476 · doc4.xml · nonDerivative · entry 2 KOSECOFF JACQUELINE B · CIK 0001209524 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 784 F1 · shares: Ordinary shares withheld to satisfy taxes. Read SEC document
August 04, 2020 Filed Aug 6, 2020 20:33 UTC	STERIS plc STE · Entity 3228	GrantOrdinary Shares	1,316	$0.00	$0.00	Disclosure SEC source: 0001209191-20-045476 · doc4.xml · nonDerivative · entry 1 KOSECOFF JACQUELINE B · CIK 0001209524 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,316 Read SEC document
May 28, 2020 Filed May 29, 2020 20:21 UTC	HOULIHAN LOKEY, INC. HLI · Entity 3553	GrantCLASS A COMMON STOCK	1,443	$0.00	$0.00	Disclosure SEC source: 0001302215-20-000078 · wf-form4_159078369193309.xml · nonDerivative · entry 1 KOSECOFF JACQUELINE B · CIK 0001209524 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,742 Read SEC document
May 21, 2020 Filed May 22, 2020 18:41 UTC	SEALED AIR CORP/DE SEE · Entity 53140	GrantCommon Stock	4,167	Not disclosed	Not disclosed	Disclosure SEC source: 0001127602-20-017689 · form4.xml · nonDerivative · entry 1 KOSECOFF JACQUELINE B · CIK 0001209524 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,167 F1 · price: Award made under the 2014 Omnibus Incentive Plan. Read SEC document
March 25, 2020 Filed Mar 27, 2020 22:12 UTC	TRINET GROUP, INC. TNET · Entity 4202	GrantCommon Stock	5,773	$0.00	$0.00	Disclosure SEC source: 0000937098-20-000122 · wf-form4_158534711101366.xml · nonDerivative · entry 3 KOSECOFF JACQUELINE B · CIK 0001209524 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,773 F2 · shares: Reflects the grant of Restricted Stock Units that convert into Common Stock, par value $0.000025 per share, of the Issuer, on a one-for-one basis. The Restricted Stock Units will vest 100% on March 25, 2021. The Restricted Stock Units are also subject to accelerated vesting upon certain events. Read SEC document
February 14, 2020 Filed Mar 27, 2020 22:12 UTC	TRINET GROUP, INC. TNET · Entity 4202	GiftCommon Stock	211	$0.00	$0.00	Disclosure SEC source: 0000937098-20-000122 · wf-form4_158534711101366.xml · nonDerivative · entry 2 KOSECOFF JACQUELINE B · CIK 0001209524 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Trust Disclosed balance after: 211 F1 · ownership.nature: Shares held directly by the Robert H. Brook and Jacqueline B. Kosecoff Family Trust (the "Trust"). The Reporting Person and her spouse serve as trustees and beneficiaries of the Trust. Read SEC document
February 14, 2020 Filed Mar 27, 2020 22:12 UTC	TRINET GROUP, INC. TNET · Entity 4202	GiftCommon Stock	211	$0.00	$0.00	Disclosure SEC source: 0000937098-20-000122 · wf-form4_158534711101366.xml · nonDerivative · entry 1 KOSECOFF JACQUELINE B · CIK 0001209524 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Read SEC document
February 12, 2020 Filed Feb 13, 2020 21:30 UTC	STERIS plc STE · Entity 3228	Exercise / conversionEmployee Stock Option (right to buy) · Derivative	3,133	$0.00 Strike: $32.34	$0.00	Disclosure SEC source: 0001209191-20-009200 · doc4.xml · derivative · entry 3 KOSECOFF JACQUELINE B · CIK 0001209524 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Ordinary Shares · 3,133 shares Expires 2020-08-04 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: This option to purchase 3,133 STERIS ordinary shares, which is fully vested, was received in conjunction with the Redomiciliation of the entity organized under the laws of the U.K. and formerly named STERIS plc ("Old STERIS") in exchange for an option to purchase 3,133 Old STERIS ordinary shares for $32.34 per share, subject to the same terms and conditions as the original Old STERIS stock option, except as otherwise required by law. Read SEC document
February 12, 2020 Filed Feb 13, 2020 21:30 UTC	STERIS plc STE · Entity 3228	SaleOrdinary Shares	3,133	$167.56	$524,965.48	Disclosure SEC source: 0001209191-20-009200 · doc4.xml · nonDerivative · entry 2 KOSECOFF JACQUELINE B · CIK 0001209524 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 955 Read SEC document
February 12, 2020 Filed Feb 13, 2020 21:30 UTC	STERIS plc STE · Entity 3228	Exercise / conversionOrdinary Shares	3,133	$32.34	$101,321.22	Disclosure SEC source: 0001209191-20-009200 · doc4.xml · nonDerivative · entry 1 KOSECOFF JACQUELINE B · CIK 0001209524 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,088 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: This balance has been reduced to reflect the correct number of shares beneficially owned following an overstatement of 40 ordinary shares in the Reporting Person's Form 4, filed on 08/21/2019. Read SEC document
February 06, 2020 Filed Feb 11, 2020 00:26 UTC	TRINET GROUP, INC. TNET · Entity 4202	Exercise / conversionRestricted Stock Units · Derivative	211	$0.00	$0.00	Disclosure SEC source: 0000937098-20-000058 · wf-form4_158138076558295.xml · derivative · entry 2 KOSECOFF JACQUELINE B · CIK 0001209524 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 211 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Restricted stock units convert to common stock of TNET on a one-to-one basis. F2 · derivative.exercise_date: The restricted stock units vested 100% on February 6, 2020. F2 · derivative.expiration_date: The restricted stock units vested 100% on February 6, 2020. Read SEC document
February 06, 2020 Filed Feb 11, 2020 00:26 UTC	TRINET GROUP, INC. TNET · Entity 4202	Exercise / conversionCommon Stock	211	Not disclosed	Not disclosed	Disclosure SEC source: 0000937098-20-000058 · wf-form4_158138076558295.xml · nonDerivative · entry 1 KOSECOFF JACQUELINE B · CIK 0001209524 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 211 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Restricted stock units convert to common stock of TNET on a one-to-one basis. Read SEC document
January 15, 2020 Filed Jan 17, 2020 22:51 UTC	TRINET GROUP, INC. TNET · Entity 4202	GrantRestricted Stock Units · Derivative	211	$0.00	$0.00	Disclosure SEC source: 0000937098-20-000030 · wf-form4_157930149476071.xml · derivative · entry 1 KOSECOFF JACQUELINE B · CIK 0001209524 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 211 Underlying: Common Stock · 211 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of TNET common stock. F2 · derivative.exercise_date: The restricted stock units ("RSUs") will vest 100% on February 6, 2020. The RSUs are also subject to accelerated vesting upon certain events. F2 · derivative.expiration_date: The restricted stock units ("RSUs") will vest 100% on February 6, 2020. The RSUs are also subject to accelerated vesting upon certain events. Read SEC document
August 06, 2019 Filed Aug 8, 2019 20:30 UTC	STERIS plc STE · Entity 3228	GrantCareer Restricted Stock Units · Derivative	26	$0.00	$0.00	Disclosure SEC source: 0001209191-19-045112 · doc4.xml · derivative · entry 5 KOSECOFF JACQUELINE B · CIK 0001209524 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,210 Underlying: Ordinary Shares · 26 shares Expires not disclosed F4 · derivative.exercise_price: Each Career Restricted Stock Unit represents the right to receive one STERIS ordinary share six months after the cessation of the Director's Board service. F5 · derivative.exercise_date: These Career Restricted Stock Units are fully vested immediately. They will be settled in STERIS ordinary shares six months after the cessation of the Director's Board service. F5 · derivative.expiration_date: These Career Restricted Stock Units are fully vested immediately. They will be settled in STERIS ordinary shares six months after the cessation of the Director's Board service. Read SEC document
August 06, 2019 Filed Aug 8, 2019 20:30 UTC	STERIS plc STE · Entity 3228	GrantDirector Stock Option (right to buy) · Derivative	119	$0.00 Strike: $152.32	$0.00	Disclosure SEC source: 0001209191-19-045112 · doc4.xml · derivative · entry 4 KOSECOFF JACQUELINE B · CIK 0001209524 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 119 Underlying: Ordinary Shares · 119 shares Expires 2029-08-06 F3 · derivative.exercise_date: These nonqualified stock options are fully vested and are exercisable immediately. Read SEC document
August 06, 2019 Filed Aug 8, 2019 20:30 UTC	STERIS plc STE · Entity 3228	GrantOrdinary Shares	525	$152.32	$79,968.00	Disclosure SEC source: 0001209191-19-045112 · doc4.xml · nonDerivative · entry 2 KOSECOFF JACQUELINE B · CIK 0001209524 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,838 F1 · price: These Ordinary Shares were issued to the Reporting Person in lieu of fees of $80,000. Read SEC document
August 06, 2019 Filed Aug 8, 2019 20:30 UTC	STERIS plc STE · Entity 3228	GrantOrdinary Shares	1,313	$0.00	$0.00	Disclosure SEC source: 0001209191-19-045112 · doc4.xml · nonDerivative · entry 1 KOSECOFF JACQUELINE B · CIK 0001209524 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,313 Read SEC document
August 06, 2019 Filed Aug 21, 2019 20:34 UTC Amendment	STERIS plc STE · Entity 3228	Tax withholdingOrdinary Shares	883	$152.32	$134,498.56	Disclosure SEC source: 0001209191-19-046992 · doc4a.xml · nonDerivative · entry 1 KOSECOFF JACQUELINE B · CIK 0001209524 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 995 F1 · shares: Amended to disclose ordinary shares withheld to satisfy taxes which were omitted from the original Form 4 filing. Read SEC document
May 16, 2019 Filed May 20, 2019 12:13 UTC	SEALED AIR CORP/DE SEE · Entity 53140	GrantCommon Stock	2,970	Not disclosed	Not disclosed	Disclosure SEC source: 0001127602-19-019079 · form4.xml · nonDerivative · entry 1 KOSECOFF JACQUELINE B · CIK 0001209524 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,610 F1 · price: Award made under the 2014 Omnibus Incentive Plan. Read SEC document
May 15, 2019 Filed May 16, 2019 20:22 UTC	STERIS plc STE · Entity 3228	Exercise / conversionDirector Stock Option (right to buy) · Derivative	3,609	$0.00 Strike: $28.08	$0.00	Disclosure SEC source: 0001209191-19-030369 · doc4.xml · derivative · entry 4 KOSECOFF JACQUELINE B · CIK 0001209524 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Ordinary Shares · 3,609 shares Expires 2019-07-31 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: This option to purchase 3,609 STERIS plc ordinary shares, which is fully vested, was received under the Scheme in exchange for an option to purchase 3,609 Old STERIS ordinary shares for $28.08 per share, subject to the same terms and conditions as the original Old STERIS stock option. Read SEC document
May 15, 2019 Filed May 16, 2019 20:22 UTC	STERIS plc STE · Entity 3228	SaleOrdinary Shares	3,609	$132.22	$477,181.98	Disclosure SEC source: 0001209191-19-030369 · doc4.xml · nonDerivative · entry 2 KOSECOFF JACQUELINE B · CIK 0001209524 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · price: Price reflects a weighted average sale price for multiple transactions ranging from $132.22 to $132.28 per share, inclusive. The Reporting Person undertakes to provide, upon request by the SEC Staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price. Read SEC document
May 15, 2019 Filed May 16, 2019 20:22 UTC	STERIS plc STE · Entity 3228	Exercise / conversionOrdinary Shares	3,609	$28.08	$101,340.72	Disclosure SEC source: 0001209191-19-030369 · doc4.xml · nonDerivative · entry 1 KOSECOFF JACQUELINE B · CIK 0001209524 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,609 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document
May 15, 2019 Filed May 16, 2019 21:47 UTC	HOULIHAN LOKEY, INC. HLI · Entity 3553	GrantCLASS A COMMON STOCK	1,853	$0.00	$0.00	Disclosure SEC source: 0001302215-19-000024 · wf-form4_155804323300918.xml · nonDerivative · entry 1 KOSECOFF JACQUELINE B · CIK 0001209524 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,299 Read SEC document
March 28, 2019 Filed Mar 28, 2019 19:30 UTC	STERIS plc STE · Entity 3228	GrantCareer Restricted Stock Units · Derivative	3,184	$0.00	$0.00	Disclosure SEC source: 0001209191-19-021603 · doc4.xml · derivative · entry 12 KOSECOFF JACQUELINE B · CIK 0001209524 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,184 Underlying: Ordinary Shares · 3,184 shares Expires not disclosed F13 · derivative.exercise_price: These career restricted stock units were assumed by STERIS pursuant to the Scheme and converted to career restricted stock units of STERIS representing the right to receive 3,184 STERIS ordinary shares. These career restricted stock units are fully vested and will be settled in STERIS ordinary shares six months after the cessation of the reporting person's board service, subject to the terms and conditions of the award agreement. F13 · derivative.exercise_date: These career restricted stock units were assumed by STERIS pursuant to the Scheme and converted to career restricted stock units of STERIS representing the right to receive 3,184 STERIS ordinary shares. These career restricted stock units are fully vested and will be settled in STERIS ordinary shares six months after the cessation of the reporting person's board service, subject to the terms and conditions of the award agreement. F13 · derivative.expiration_date: These career restricted stock units were assumed by STERIS pursuant to the Scheme and converted to career restricted stock units of STERIS representing the right to receive 3,184 STERIS ordinary shares. These career restricted stock units are fully vested and will be settled in STERIS ordinary shares six months after the cessation of the reporting person's board service, subject to the terms and conditions of the award agreement. Read SEC document
March 28, 2019 Filed Mar 28, 2019 19:30 UTC	STERIS plc STE · Entity 3228	GrantDirector Stock Option (right to buy) · Derivative	436	Not disclosed Strike: $114.74	Not disclosed	Disclosure SEC source: 0001209191-19-021603 · doc4.xml · derivative · entry 11 KOSECOFF JACQUELINE B · CIK 0001209524 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 436 Underlying: Ordinary Shares · 436 shares Expires 2028-08-09 F12 · price: This option to purchase 436 STERIS ordinary shares, which is fully vested, was received under the Scheme in exchange for an option to purchase 436 Old STERIS ordinary shares for $114.74 per share, subject to the same terms and conditions as the original Old STERIS stock option. F12 · derivative.exercise_date: This option to purchase 436 STERIS ordinary shares, which is fully vested, was received under the Scheme in exchange for an option to purchase 436 Old STERIS ordinary shares for $114.74 per share, subject to the same terms and conditions as the original Old STERIS stock option. Read SEC document
March 28, 2019 Filed Mar 28, 2019 19:30 UTC	STERIS plc STE · Entity 3228	GrantDirector Stock Option (right to buy) · Derivative	927	Not disclosed Strike: $86.23	Not disclosed	Disclosure SEC source: 0001209191-19-021603 · doc4.xml · derivative · entry 10 KOSECOFF JACQUELINE B · CIK 0001209524 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 927 Underlying: Ordinary Shares · 927 shares Expires 2027-08-09 F11 · price: This option to purchase 927 STERIS ordinary shares, which is fully vested, was received under the Scheme in exchange for an option to purchase 927 Old STERIS ordinary shares for $86.23 per share, subject to the same terms and conditions as the original Old STERIS stock option. F11 · derivative.exercise_date: This option to purchase 927 STERIS ordinary shares, which is fully vested, was received under the Scheme in exchange for an option to purchase 927 Old STERIS ordinary shares for $86.23 per share, subject to the same terms and conditions as the original Old STERIS stock option. Read SEC document
March 28, 2019 Filed Mar 28, 2019 19:30 UTC	STERIS plc STE · Entity 3228	GrantDirector Stock Option (right to buy) · Derivative	3,781	Not disclosed Strike: $71.40	Not disclosed	Disclosure SEC source: 0001209191-19-021603 · doc4.xml · derivative · entry 9 KOSECOFF JACQUELINE B · CIK 0001209524 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,781 Underlying: Ordinary Shares · 3,781 shares Expires 2026-08-10 F10 · price: This option to purchase 3,781 STERIS ordinary shares, which is fully vested, was received under the Scheme in exchange for an option to purchase 3,781 Old STERIS ordinary shares for $71.40 per share, subject to the same terms and conditions as the original Old STERIS stock option. F10 · derivative.exercise_date: This option to purchase 3,781 STERIS ordinary shares, which is fully vested, was received under the Scheme in exchange for an option to purchase 3,781 Old STERIS ordinary shares for $71.40 per share, subject to the same terms and conditions as the original Old STERIS stock option. Read SEC document
March 28, 2019 Filed Mar 28, 2019 19:30 UTC	STERIS plc STE · Entity 3228	GrantDirector Stock Option (right to buy) · Derivative	4,110	Not disclosed Strike: $64.05	Not disclosed	Disclosure SEC source: 0001209191-19-021603 · doc4.xml · derivative · entry 8 KOSECOFF JACQUELINE B · CIK 0001209524 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,110 Underlying: Ordinary Shares · 4,110 shares Expires 2025-08-31 F9 · price: This option to purchase 4,110 STERIS ordinary shares, which is fully vested, was received under the Scheme in exchange for an option to purchase 4,110 Old STERIS ordinary shares for $64.05 per share, subject to the same terms and conditions as the original Old STERIS stock option. F9 · derivative.exercise_date: This option to purchase 4,110 STERIS ordinary shares, which is fully vested, was received under the Scheme in exchange for an option to purchase 4,110 Old STERIS ordinary shares for $64.05 per share, subject to the same terms and conditions as the original Old STERIS stock option. Read SEC document
March 28, 2019 Filed Mar 28, 2019 19:30 UTC	STERIS plc STE · Entity 3228	GrantDirector Stock Option (right to buy) · Derivative	4,584	Not disclosed Strike: $51.53	Not disclosed	Disclosure SEC source: 0001209191-19-021603 · doc4.xml · derivative · entry 7 KOSECOFF JACQUELINE B · CIK 0001209524 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,584 Underlying: Ordinary Shares · 4,584 shares Expires 2024-08-06 F8 · price: This option to purchase 4,584 STERIS ordinary shares, which is fully vested, was received under the Scheme in exchange for an option to purchase 4,584 Old STERIS ordinary shares for $51.53 per share, subject to the same terms and conditions as the original Old STERIS stock option. F8 · derivative.exercise_date: This option to purchase 4,584 STERIS ordinary shares, which is fully vested, was received under the Scheme in exchange for an option to purchase 4,584 Old STERIS ordinary shares for $51.53 per share, subject to the same terms and conditions as the original Old STERIS stock option. Read SEC document
March 28, 2019 Filed Mar 28, 2019 19:30 UTC	STERIS plc STE · Entity 3228	GrantDirector Stock Option (right to buy) · Derivative	4,657	Not disclosed Strike: $43.92	Not disclosed	Disclosure SEC source: 0001209191-19-021603 · doc4.xml · derivative · entry 6 KOSECOFF JACQUELINE B · CIK 0001209524 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,657 Underlying: Ordinary Shares · 4,657 shares Expires 2023-08-08 F7 · price: This option to purchase 4,657 STERIS ordinary shares, which is fully vested, was received under the Scheme in exchange for an option to purchase 4,657 Old STERIS ordinary shares for $43.92 per share, subject to the same terms and conditions as the original Old STERIS stock option. F7 · derivative.exercise_date: This option to purchase 4,657 STERIS ordinary shares, which is fully vested, was received under the Scheme in exchange for an option to purchase 4,657 Old STERIS ordinary shares for $43.92 per share, subject to the same terms and conditions as the original Old STERIS stock option. Read SEC document
March 28, 2019 Filed Mar 28, 2019 19:30 UTC	STERIS plc STE · Entity 3228	GrantDirector Stock Option (right to buy) · Derivative	3,218	Not disclosed Strike: $32.36	Not disclosed	Disclosure SEC source: 0001209191-19-021603 · doc4.xml · derivative · entry 5 KOSECOFF JACQUELINE B · CIK 0001209524 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,218 Underlying: Ordinary Shares · 3,218 shares Expires 2022-08-03 F6 · price: This option to purchase 3,218 STERIS ordinary shares, which is fully vested, was received under the Scheme in exchange for an option to purchase 3,218 Old STERIS ordinary shares for $32.36 per share, subject to the same terms and conditions as the original Old STERIS stock option. F6 · derivative.exercise_date: This option to purchase 3,218 STERIS ordinary shares, which is fully vested, was received under the Scheme in exchange for an option to purchase 3,218 Old STERIS ordinary shares for $32.36 per share, subject to the same terms and conditions as the original Old STERIS stock option. Read SEC document
March 28, 2019 Filed Mar 28, 2019 19:30 UTC	STERIS plc STE · Entity 3228	GrantDirector Stock Option (right to buy) · Derivative	3,121	Not disclosed Strike: $31.61	Not disclosed	Disclosure SEC source: 0001209191-19-021603 · doc4.xml · derivative · entry 4 KOSECOFF JACQUELINE B · CIK 0001209524 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,121 Underlying: Ordinary Shares · 3,121 shares Expires 2021-08-03 F5 · price: This option to purchase 3,121 STERIS ordinary shares, which is fully vested, was received under the Scheme in exchange for an option to purchase 3,121 Old STERIS ordinary shares for $31.61 per share, subject to the same terms and conditions as the original Old STERIS stock option. F5 · derivative.exercise_date: This option to purchase 3,121 STERIS ordinary shares, which is fully vested, was received under the Scheme in exchange for an option to purchase 3,121 Old STERIS ordinary shares for $31.61 per share, subject to the same terms and conditions as the original Old STERIS stock option. Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.